非洲人群UMOD基因型与尿调节素决定因素
在非洲-PREDICT和PURE-NWP-SA两项横断面研究中,比较黑人和白人青年及中年黑人的UMOD-PDILT SNPs与尿uUMOD水平。黑人uUMOD及uUMOD/肌酐较低,rs12917707风险等位基因更常见,且种族与SNP对uUMOD/肌酐关系存在交互作用。
要点
- 黑人uUMOD及uUMOD/肌酐水平低于白人。
- rs12917707风险等位基因在黑人中更普遍。
- 种族与3个SNPs对uUMOD/肌酐关系存在显著交互作用。
核心结论
- uUMOD的临床和遗传决定因素存在种族差异,尤其种族与CKD风险SNPs对uUMOD的关系存在交互作用。
研究设计与样本
- 横断面观察性研究,纳入非洲-PREDICT研究中1202名年轻黑人和白人成人及PURE-NWP-SA研究中1943名中年黑人成人。
主要发现
- 黑人参与者绝对uUMOD和uUMOD/肌酐水平低于白人参与者。
- rs12917707主要CKD风险等位基因在黑人中更普遍,风险等位基因纯合子显著多于白人。
- 单倍型分析提示黑人UMOD-PDILT位点重组事件更多且连锁不平衡碎片化。
- 多变量分析显示白人uUMOD/肌酐与rs12917707和rs12446492风险等位基因相关,黑人则与较高血清肾素和较低尿白蛋白/肌酐比相关。
- 多回归模型解释uUMOD/肌酐变异百分比在白人中为23%,黑人中为8%。
临床怎么用
- 分析尿调节素在肾功能中作用时应考虑种族差异。
- 解读GWAS和制定精准医学建议时需考虑种族对SNP-uUMOD关系的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Single-nucleotide polymorphisms (SNPs) in the UMOD -PDILT genetic locus are associated with chronic kidney disease (CKD) in European populations, through their effect on urinary uromodulin (uUMOD) levels. The genetic and nongenetic factors associated with uUMOD in African populations remain unknown. METHODS: Clinical parameters, 3 selected UMOD-PDILT SNPs and uUMOD levels were obtained in 1202 young Black and White adults from the African-PREDICT study and 1943 middle aged Black adults from the PURE-NWP-SA study, 2 cross-sectional, observational studies. RESULTS: Absolute uUMOD and uUMOD/creatinine levels were lower in Black participants compared to White participants. The prime CKD-risk allele at rs12917707 was more prevalent in Black individuals, with strikingly more risk allele homozygotes compared to White individuals. Haplotype analysis of the UMOD-PDILT locus predicted more recombination events and linkage disequilibrium (LD) fragmentation in Black individuals. Multivariate testing and sensitivity analysis showed that higher uUMOD/creatinine associated specifically with risk alleles at rs12917707 and rs12446492 in White participants and with higher serum renin and lower urine albumin-to-creatinine ratio in Black participants, with a significant interaction of ethnicity on the relationship between all 3 SNPs and uUMOD/creatinine. The multiple regression model explained a greater percentage of the variance of uUMOD/creatinine in White adults compared to Black adults (23% vs. 8%). CONCLUSION: We evidenced ethnic differences in clinical and genetic determinants of uUMOD levels, in particular an interaction of ethnicity on the relationship between CKD-risk SNPs and uUMOD. These differences should be considered when analyzing the role of uromodulin in kidney function, interpreting genome-wide association studies (GWAS), and precision medicine recommendations.
引用
- Strauss-Kruger M, Olinger E, Hofmann P, et al. UMOD Genotype and Determinants of Urinary Uromodulin in African Populations. Kidney Int Rep. 2024. PMID: 39698369. doi:10.1016/j.ekir.2024.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。